<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The goal of the present study was to test the impact of administration time of the <z:chebi fb="0" ids="2719,48432">angiotensin II</z:chebi> type 1-receptor blocker <z:chebi fb="0" ids="3347">candesartan</z:chebi> on cerebral blood flow (CBF), <z:mpath ids='MPATH_124'>infarct</z:mpath> size, and neuroscore in transient <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Therefore, 1-hour middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) was followed by reperfusion </plain></SENT>
<SENT sid="2" pm="."><plain>Rats received 0.5-mg/kg <z:chebi fb="0" ids="3347">candesartan</z:chebi> intravenously 2 hours before MCAO (pretreatment), 24 hours after MCAO, every 24 hours after MCAO, or 2 hours before and every 24 hours after MCAO </plain></SENT>
<SENT sid="3" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> size (mm3) and a neuroscore at day 7 were compared with controls </plain></SENT>
<SENT sid="4" pm="."><plain>CBF was quantified by radiolabeled microspheres and laser-Doppler flowmetry </plain></SENT>
<SENT sid="5" pm="."><plain>Compared with controls (95 +/- 8), <z:mpath ids='MPATH_124'>infarct</z:mpath> size in <z:chebi fb="0" ids="3347">candesartan</z:chebi>-treated groups was smaller (59 +/- 5, 68 +/- 10, 28 +/- 3, and 15 +/- 3, respectively; P&lt;0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>Although there was no difference in neuroscore between pretreatment and controls (1.55 +/- 0.18, 1.80 +/- 0.13), other treatment regimens resulted in improved neuroscores (1.33 +/- 0.16, 1.11 +/- 0.11, 0.73 +/- 0.15; P&lt;0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>CBF in pretreated animals at 0.5 hours after MCAO was significantly higher than in controls (0.58 +/- 0.09 mL x g(-1) x min(-1) and 44% +/- 7% of baseline compared with 0.49 +/- 0.06 mL x g(-1) x min(-1) and 37% +/- 6%, microspheres and laser-Doppler flowmetry; P&lt;0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>Thus, <z:chebi fb="0" ids="3347">candesartan</z:chebi> reduces <z:mpath ids='MPATH_124'>infarct</z:mpath> size even if administered only during reperfusion </plain></SENT>
<SENT sid="9" pm="."><plain>Apart from pretreatment, other treatment regimens result in significantly improved neuroscores </plain></SENT>
<SENT sid="10" pm="."><plain>In the <z:hpo ids='HP_0011009'>acute</z:hpo> phase of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, <z:chebi fb="0" ids="3347">candesartan</z:chebi> increases CBF </plain></SENT>
</text></document>